Bad Abbach, Germany
A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.
Phase
2/3Span
225 weeksSponsor
argenxBad Abbach
Recruiting
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Phase
2/3Span
200 weeksSponsor
GlaxoSmithKlineBad Abbach
Recruiting
1-2 of 2